While the Type I IFN axis has been previously implicated in SSc in genome-wide association studies and reports of the presence of an interferon signature in patients [22], our study showing the IFNAR-dependence of a more severe skin phenotype further supports a potential role of Type I IFNs as a driver of dermal disease in SSc. This evidence concerns the gene IFNAR1 and systemic sclerosis.